Studying the different characteristics of chronic obstructive pulmonary disease in primary care using near-patient testing and relating this to treatment responses during an acute exacerbation

niversity of Oxford0 sites300 target enrollmentAugust 20, 2015

Overview

No summary available.

Registry

who.int

Start Date

August 20, 2015

End Date

December 31, 2017

Last Updated

4 years ago

Study Type

Observational

Sex

All

Sponsor

•1\. Participant is willing and able to give informed consent for participation in the study
•2\. Male or female, aged 40 years or above.
•3\. Known diagnosis of COPD (either diagnosis made in primary or secondary care) as per national and international guidelines (NICE, 2010 \& GOLD 2013\), irrespective of severity
•4\. Current or ex\-smoker
•5\. Smoking pack year history \>10
•6\. Spirometry confirming fixed airflow obstruction (FEV1/FVC ratio \<0\.7\)
•Target Gender: Male \& Female; Lower Age Limit 40 years

•1\. History of atopic childhood asthma
•2\. Current history of primary lung malignancy or current active pulmonary TB
•3\. Upon questioning the participant is HIV, hepatitis B or C positive
•4\. Clinically relevant disease or disorder (past or present) which in the opinion of the investigator may either put the subject at risk because of participating in the study or may influence the results of the study or the subject’s ability to participate in the study
•5\. Any clinically relevant lung disease other than COPD, considered by the investigator to be the primary diagnosis. For example mild to moderate bronchiectasis is acceptable in addition to COPD unless the bronchiectasis is considered to be the primary diagnosis
•6\. An alternative cause for the increase in symptoms of COPD that are unrelated to an exacerbation such as
•6\.1\. Suspicion or clinical evidence of pneumonia
•6\.2\. High probability and suspicion of pulmonary embolism
•6\.3\. Suspicion or clinical evidence of a pneumothorax
•6\.4\. Primary ischaemic event – ST or non ST elevation myocardial infarct and left ventricular failure (i.e., not an exacerbation of COPD)